UPC_APP_9340/2024

Intravenous infusion system with dosing device

OtherPreliminary ObjectionDusseldorf LDPreliminary objection—

Parties

Claimants

F. Hoffmann-La Roche AG(Roche Group)
Roche Diabetes Care GmbH(Roche Group)

Reps: Christof Augenstein (Kather Augenstein Rechtsanwälte PartGmbB); Sophie Prudent (Kather Augenstein Rechtsanwälte PartGmbB); Katharina Brandt (Kather Augenstein Rechtsanwälte PartGmbB)

Respondents

Tandem Diabetes Care, Inc.
Tandem Diabetes Care Europe B.V.
VitalAire GmbH
Dinno Santé s.a.i.
Air Liquide Healthcare Nederland B.V.
Rubin Medical ApS

Reps: Charlotte Garnitsch (Taylor Wessing N.V.); Wim Maas (Taylor Wessing N.V.); Christine Kanz (Hoyng Rokh Monegier)

Judges

ThomJudge-Rapporteur

Patents

EP1970677

CPC codes: A61M5/168, A61M5/16854, A61M5/152, A61M2205/3379, A61M5/14216, A61M5/14, F04B53/162, A61M5/31525, A61M2005/16863, A61M5/16859, A61M5/16881, A61M5/16809…

Sector: Measurement & Testing

Outcome

Procedural only

Filed: —

First decided: Apr 11, 2024

Language: —